TP53 and cancer: Thus, the lead molecule PK11007 was shown to stabilize the p53-Y220C core domain by up to 3 °C in experiments using differential scanning fluorimetry and to induce concentration-dependent upregulation of p53 target genes (P21 and PUMA) in cancer cell lines.